Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CO/Grand Junction
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Grand Junction, CO

Studies commonly pay $75 to $4,500 per completed study

54 clinical trials are currently recruiting participants within 30 miles of Grand Junction. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

54studies recruiting
2+research centers nearby
2condition categories
Live from the NIH registry

Studies recruiting near Grand Junction right now

Top 25 of 54 recruiting studies, sorted by proximity — each links to its official registry page

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 614 participants sought
Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06170788)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 400 participants sought
Research Site — Grand Junction, Colorado (1.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07291037)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Intermountain Health St. Mary's Regional Hospital ( Site 0054) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06966700)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 714 participants sought
Cancer Centers of Colorado St. Mary's Regional Hospital — Grand Junction, Colorado (1.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06758401)

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer Phase 3 Interventional 330 participants sought
Colorado West Healthcare System dba Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07005128)

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease N/A Observational 1,500 participants sought
St. Mary's Hospital and Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT02071134)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07225946)

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Persistent Corneal Epithelial Defect Phase 2 Interventional 84 participants sought
Glaukos Investigative Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Glaukos Corporation
See eligibility & contact on ClinicalTrials.gov (NCT05966493)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Grand Junction, Colorado (1.9 mi) · Sponsor: TG Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06433752)

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Breast Neoplasms Phase 3 Interventional 1,000 participants sought
St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado ( Site 0021) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07060807)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Colorado West Healthcare System-Grand Valley Oncology ( Site 0165) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8 Phase 2 Interventional 94 participants sought
Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04205968)

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Advanced Breast Cancer Phase 3 Interventional 510 participants sought
Clinical Trial Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Olema Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06016738)

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Glaucoma Phase 2, Phase 3 Interventional 610 participants sought
Glaukos Investigative Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Glaukos Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07075718)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine Phase 3 Interventional 600 participants sought
Boeson Research GJT — Grand Junction, Colorado (1.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04743141)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Non-small Cell Lung Cancer Phase 3 Interventional 1,000 participants sought
Local Institution - 0500 — Grand Junction, Colorado (1.9 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06561386)

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

Age Related Cataracts Phase 2 Interventional 40 participants sought
ICON Eye Care — Grand Junction, Colorado (1.9 mi) · Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07395986)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Intermountain Health St. Mary's Regional Hospital ( Site 0025) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

Open Angle Glaucoma (OAG) N/A Interventional 165 participants sought
ICON Eye Care — Grand Junction, Colorado (1.9 mi) · Sponsor: Avisi Technologies Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07220876)
Actively enrolling

Studies you may be able to join near Grand Junction

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Grand Junction

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Primary Care Partners Inc.

★ 3.4
3150 N 12th St, Grand Junction, CO 81506
(970) 256-5211
"I spent one of the worst nights in Delta hospital that I ever had .The bed had half the buttons didn't work and the mattress i had seams like it had …"
— Leroy Foreman, 3★

Western Slope Veterinary Diagnostic Laboratory, CSU

3164 B 1/2 Rd, Grand Junction, CO 81503
(970) 243-0673

Clinical trials in Grand Junction: what's recruiting

The Grand Junction area currently has 54 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Grand Junction, the most active research areas are:

  • Cancer & Oncology16 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Grand Junction, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Grand Junction

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Grand Junction participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Grand Junction pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Grand Junction, CO?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Grand Junction?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Junction typically complete one or two studies per year.

Paid clinical trials near Grand Junction

Other metros within reach

Provo, UT119 Lakewood, CO1,594 Thornton, CO1,597 Denver, CO1,594 Salt Lake City, UT1,155 Fort Collins, CO159 Colorado Springs, CO207 Aurora, CO1,561

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Grand Junction Bladder Issues Due To Spinal Cord Injury in Grand Junction All conditions

More of CO

Thornton1,597 Denver1,594 Lakewood1,594 Aurora1,561 Colorado Springs207 Greeley161 Fort Collins159

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts